RNS Number : 4091U Renalytix AI PLC 06 April 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure
RNS Number : 1874S Renalytix AI PLC 15 March 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") Update on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics NEW YORK , March 15, 2021 - Renalytix AI plc (LSE : RENX) (NASDAQ:
RNS Number : 2460R Renalytix AI PLC 04 March 2021 Renalytix AI plc ("RenalytixAI", the "Company" or the "Group") Issue of shares under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting Rights New York , 4 March 2021 - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX),, an
RNS Number : 8363Q Renalytix AI PLC 02 March 2021 RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021 NEW YORK , March 2, 2021 - Renalytix AI plc (LSE : RENX) (NASDAQ: RNLX) ("RenalytixAI" or the "Company"), an artificial intelligence-enabled in vitro diagnostics
RNS Number : 8349Q Renalytix AI PLC 02 March 2021 Renalytix AI plc ("RenalytixAI", the "Company" or the "Group") Half-year Report Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), ("RenalytixAI" or the "Company"), an artificial intelligence-enabled in vitro diagnostics company, focused on
RNS Number : 1616Q Renalytix AI PLC 24 February 2021 This announcement contains inside information Renalytix AI plc (" RenalytixAI " or the " Company ") The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health Innovative partnership to enable health system-wide
RNS Number : 9649P Renalytix AI PLC 23 February 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") RenalytixAI to announce Financial Results for six and three months ended December 31, 2020 NEW YORK , February 23, 2021 - Renalytix AI plc (LSE : RENX) (NASDAQ: RNLX), the
RNS Number : 9849N Renalytix AI PLC 04 February 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health Event Featuring Leading Clinicians, Biotech Innovators and Federal Health
RNS Number : 6057L Renalytix AI PLC 13 January 2021 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders
RNS Number : 4713L Renalytix AI PLC 13 January 2021 This announcement contains inside information Renalytix AI plc (" RenalytixAI " or the " Company ") Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics